Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

GSK and other Olympic sponsors may face hacking attack

IT security firm claims ‘hacktivist’ network Anonymous could target websites of London 2012 partners

GlaxoSmithKline could be targeted by 'hacktivist' network Anonymous, according to reports.

IT security firm Radware claims to have found evidence the hacking network, which earlier this year took down several UK government sites, is preparing to launch a denial-of-service attack on the pharma company's website.

Carl Herberger, vice president of security solutions at Radware, told Network World US that online posts indicate Anonymous could attack GSK and telecoms firm BT, both of whom are prominent sponsors of the London 2012 Games.

While there is, as expected, no way of verifying the information, which comes from someone claiming links with Anonymous, Herberger said some previous attacks have followed a similar pattern.

The potential threat emerged just over a year Bayer's Italian website was hit by 'illegal interference' by hackers affiliated with Anonymous in June, 2011.

Meanwhile, a separate UK group called The Script Kiddies took over Pfizer's Facebook page last July, defacing it and adding links to several articles critical of the pharma company.

1st August 2012

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Double Helix

Double Helix is an independent healthcare consultancy with headquarters in London and offices in the US and Singapore. Established in...

Latest intelligence

A new reality for healthcare
When mobile phones came onto the mass market it would have been difficult to see how they were to develop into the ubiquitous multimedia devices they are now. Their power,...
Digital-green-grey.jpg
Are you getting these benefits from your digital technology?
Your organisation switched from ‘paper to glass’, buying the latest mobile devices and hiring digital agencies to fill them with eye-catching content. But what happened?...
Alzheimer's: the numbers we cannot forget
In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as looking at the some of the...

Infographics